Carl Zeiss Meditec AGXSWX:AFX +1.21%79 OCF Yield % is 10.41 as of Jun. 25, 2026, which is 332% above its 10-year median of 2.41. GuruFocus rates XSWX:AFX with a GF Score™ of 79/100 and a GF Value™ of CHF66.55 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Carl Zeiss Meditec AG ranks better than 87.68% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Carl Zeiss Meditec AG's OCF Yield % or its related term are showing as below:
XSWX:AFX'
s OCF Yield % Range Over the Past 10 Years
Min: -0.04 Med: 2.41 Max: 13.15
Current: 10.41
During the past 13 years, the highest OCF Yield % of Carl Zeiss Meditec AG was 13.15%. The lowest was -0.04%. And the median was 2.41%.
XSWX:AFX's OCF Yield % is ranked better than 87.68% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.76
vs XSWX:AFX: 10.41
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Carl Zeiss Meditec AG OCF Yield % Related Terms
Carl Zeiss Meditec AG OCF Yield % Historical Data
* Premium members only.
The historical data trend for Carl Zeiss Meditec AG's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:AFX vs ISRG, BDX, MDLN: OCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carl Zeiss Meditec AG OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Carl Zeiss Meditec AG's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG (XSWX:AFX) has a OCF Yield % of 10.41 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Carl Zeiss Meditec AG and its competitors. This is 332% above median its historical median of 2.41. According to the industry distribution chart, Carl Zeiss Meditec AG ranks #105 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 12.3%.
Is Carl Zeiss Meditec AG's OCF Yield % too high?
Carl Zeiss Meditec AG's current OCF Yield % of 10.41 is 332% above median its 10-year median of 2.41. The Medical Devices & Instruments industry median OCF Yield % is 1.76. Carl Zeiss Meditec AG's value of 10.41 is 491.5% above this industry median. Based on the distribution chart, Carl Zeiss Meditec AG ranks #105 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Carl Zeiss Meditec AG has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Carl Zeiss Meditec AG ranks #105 out of 852 companies for OCF Yield %. This places Carl Zeiss Meditec AG in the top 12% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.76. Carl Zeiss Meditec AG's value of 10.41 is 491.5% above this benchmark. While the company's 10-year median is 2.41 vs. the industry median of 1.76, Carl Zeiss Meditec AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.76, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carl Zeiss Meditec AG's current OCF Yield % of 10.41 is 491.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Carl Zeiss Meditec AG and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carl Zeiss Meditec AG's current OCF Yield % is 10.41, which is 332% above median its own 10-year median of 2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG (XSWX:AFX) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF66.55, compared to a current price of CHF25.10 — trading 62.3% below its estimated fair value. The current OCF Yield % is 10.41, which is 332% above median its 10-year median of 2.41 and 491.5% above the Medical Devices & Instruments industry median of 1.76. Carl Zeiss Meditec AG's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Carl Zeiss Meditec AG (XSWX:AFX), the current OCF Yield % is 10.41 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued.
The current stock price of CHF25.10 is trading 62.3% below its estimated GF Value™ of CHF66.55.
GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.
Key valuation signals for XSWX:AFX:
OCF Yield %: 10.41 (332% above median its 10-year median of 2.41)
GF Value™: CHF66.55 vs. price of CHF25.10 (62.3% below fair value)
Industry Position: 491.5% above the Medical Devices & Instruments median (#105 of 852)
No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
79GF Score
Get the complete analysis for XSWX:AFX
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:AFX has been successfully added to your 
